pressed (RNA and protein) in most hypomethylated tumors (Fig. 3C ) is consistent with a mechanism in which a gain of chromosome 15 contributes, at least in part, to the elevated expression of c-myc. Moreover, c-myc expression was lower in the two tumors that did not show trisomy 15 than in the other tumors (Fig. 3C) .
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Our results show that genomic hypomethylation causes tumorigenesis in mice and is associated with the acquisition of additional genomic changes. Consistent with this, genomic hypomethylation was found to promote tumorigenesis in a different mouse tumor model and to increase the rate of LOH in cultured fibroblasts (23) . However, it remains possible that DNA hypomethylation contributes to tumorigenesis through other mechanisms unrelated to chromosomal instability. The phenotype of hypomethylated mice is also consistent with that of Suv39h histone methyltransferase mutant mice; hence, DNA and histone methylation, pericentric chromatin structure, and the maintenance of chromosomal stability may be linked (30) .
DNA methyltransferase inhibitors such as 5-aza-2Ј-deoxycytidine have been used successfully to treat cancer in humans (19, 31) and mice (32, 33) . The efficacy of these drugs is presumably due to their ability to reverse the epigenetic silencing of tumor suppressor genes. In light of our results, however, this therapeutic strategy should perhaps be considered a doubleedged sword: Genomic demethylation may protect against some cancers such as intestinal tumors in the Apc Min mouse model (32) but may promote genomic instability and LOH (20, 23) and increase the risk of cancer in other tissues, as seen in hypomethylated mutant mice. (11) . As expected, Fkh2p binds strongly and Fkh1p weakly to the upstream activating sequence (UAS) region on the promoter (5) (Fig. 1B) . The majority of Fkh1p is associated with the first 600 base pairs (bp) of the transcribed region, whereas, in addition to UAS binding, a second peak of Fkh2p is present at the beginning of the coding region, extending toward the 3Ј end of the gene. The unexpected presence of Fkh1p and Fkh2p in the CLB2 coding region suggests a role in transcriptional elongation, in addition to their well-known function in CLB2 activation involving UAS association.
Regulation of Elongating
We investigated the distribution of RNAPII over the CLB2 gene ( Fig. 1C; fig. S1 ). In wildtype (WT), the distribution of RNAPII (Rbp3- *To whom correspondence should be addressed. Email: emellor@molbiol.ox.ac.uk HA) suggests that enzyme accumulates at the beginning of the coding region. However, RNA-PII distribution was different in strains lacking Fkh1p (fkh1⌬) or Fkh2p (fkh2⌬). In fkh1⌬, RNAPII fails to accumulate at the beginning of the coding region, and instead the enzyme is concentrated toward the end of the gene. As expected, fkh2⌬ leads to a substantial reduction in the amount of RNAPII at CLB2, but the majority is found at the beginning of the coding region. These initial observations lead us to conclude, first, that Fkh transcription factors, believed to be localized exclusively to promoters, are also associated with transcribed regions, and second, that these factors influence in opposite ways the distribution of RNAPII over the gene. The observation that RNAPII accumulates at the beginning of the coding region of CLB2 indicates that a block to elongation occurs at this position and that this requires Fkh1p.
We set out to test the hypothesis that the Fkh factors differentially influence elongating RNA-PII by investigating the effect of 6-azauracil (6AU) on the growth of fkh1⌬ and fkh2⌬ mutants. The phenotype of 6AU sensitivity is linked to transcription elongation (12) as treatment depletes pools of guanosine 5Ј-triphosphate (GTP). Consequently, RNAPII cannot elongate efficiently, and elongation factors such as TFIIS (Dst1p) and Spt4p become crucial for growth (13, 14) . We show that fkh2⌬, like dst1⌬ and spt4⌬ strains, displays sensitivity to 6AU that is suppressed by guanine ( Fig. 2A; fig.  S2A ). Furthermore, phenotypes in combined fkh2⌬ spt4⌬ or fkh2⌬ dst1⌬ mutants are more severe, consistent with a positive role for Fkh2p in transcription elongation. A full genetic analysis is shown in fig. S2 . By contrast, fkh1⌬ is resistant to 6AU and suppresses the phenotypes of the fkh2⌬ and spt4⌬ strains, suggesting an opposing function.
WT strains survive 6AU treatment because the IMD2 gene is induced to replenish GTP pools (15) . Northern blot analysis suggests that IMD2 is a target of Fkh regulation ( fig. S2C ). The IMD2 promoter lacks Fkh binding sites (16) and is not associated with Fkh factors. However, association of the Fkh factors with the coding region of IMD2 paralleled that observed at CLB2, but only when IMD2 transcription was induced with 6AU ( Fig. 2B; fig. S1C ). A similar pattern of Fkh factor association with the coding region ( Fig. 3B; figs. S3 and S5C) and Fkh-dependent distribution of RNAPII ( Fig. 3E; figs. S5B and S6B) was observed at three further loci, PMA1, MET16, and pTEF: Kan R , not previously identified as targets of Fkh factors (2, 16) , suggesting that many unrelated genes may be influenced by Fkh factors when transcribed.
We sought to establish how Fkh1p and Fkh2p influence RNAPII. The heptad repeat (Tyr-Ser-Pro-Thr-Ser-Pro-Ser) 27 of the C-terminal repeat domain (CTD) of the largest subunit of RNAPII becomes differentially phosphorylated at Ser 5 and Ser 2 during elongation and recruits activities for co-transcriptional processing of the transcript (17) . We performed ChIP analysis with antibodies specific for CTD phosphorylated at either Ser 5 or Ser 2 ( Fig. 3D ; figs. S4 to S6). In WT, Ser 5 phosphorylation decreased but Ser 2 phosphorylation increased between the 5Ј and 3Ј end of the genes, as observed previously (18) . In fkh2⌬, dst1⌬, and spt4⌬, the pattern of Ser 5 and Ser 2 phosphorylation is more constant across the gene. In these strains, the majority of RNAPII is located at the 5Ј part of the coding region ( Fig. 3E; figs. S5B and S6B), suggesting there is a defect in the release of RNAPII into the elongation phase of expression. This raises the possibility that failure to release RNAPII disturbs the temporal control of Ser 5 and Ser 2 phosphorylation, leading to a low level of hyperphosphorylated RNAPII at 3Ј regions. By contrast, in the fkh1⌬ strain, phosphorylation of Ser 5 at all three promoters is markedly reduced, and this modification remains low throughout the coding regions ( Fig.  3D; figs. S4 to S6). Interestingly, Fkh1p is also required for normal association of Kin28p, the Ser 5 kinase (19) at PMA1 (Fig. 3C) and IMD2 ( fig. S6C ). This supports a link between Fkh1p and early transcription events. Furthermore, Ser 2 phosphorylation is barely detectable in fkh1⌬ and does not increase as RNAPII reaches the 3Ј end of the genes ( Fig. 3D; figs. S4 to S6). Ser 2 phosphorylation is not dependent on Kin28p, suggesting that activity of the serine-2 kinase, or regulation of the CTD phosphatase, is also defective in fkh1⌬ (20) .
Because the increase in Ser 2 phosphorylation in coding regions is associated with pre-mRNA 3Ј end processing (21) , it seemed likely that fkh1⌬ is also defective in pre-mRNA 3Ј end formation. We therefore looked for transcriptional interference between the tandem GAL10 and GAL7 genes that occurs when GAL10 termination is disrupted (22, 23) with the use of a tandem reporter construct containing the GAL10-7 intergenic region ( Fig. 4A; fig. S7A ). Here, transcription running through the GAL10 terminator reduces green fluorescent protein (GFP) produced by the downstream gene. WT expresses GFP from the GAL7 promoter regardless of whether the interfering upstream gene is active or not. This is also the case in fkh2⌬, dst1⌬, and spt4⌬, although the efficiency of expression may be reduced. In contrast, in fkh1⌬ expression from the downstream GAL7 promoter is reduced by 80% when the interfering upstream gene is expressed. To confirm a 3Ј end formation defect for fkh1⌬, reverse transcription polymerase chain reaction (RT-PCR) was performed to detect steady-state RNA complementary to 3Ј sequences of the IMD2 gene. This revealed extended transcripts in fkh1⌬ but not WT or fkh2⌬ (Fig. 4B) . These data strongly suggest that Fkh1p plays a role in mRNA 3Ј end formation.
To confirm that the hypophosphorylated RNAPII in fkh1⌬ is defective in pre-mRNA 3Ј end formation, we used a transcription run-on (TRO) assay. Here, incorporation of a pulse of radiolabel into nascent transcripts indicates engaged RNAPII. We investigated the profile of incorporation of labeling at IMD2 (Fig. 4C) and pTEF::Kan R ( fig. S7B ) on plasmids. As expected, in WT signals dropped to near background after the polyadenylation [poly(A)] site. By contrast, at the 3Ј side of the poly(A) site, signals in fkh1⌬ are of higher intensity than in WT, consistent with active transcription past the poly(A) site, which confirms the 3Ј end formation defect. Furthermore, at IMD2, the signal at probe 1 in fkh1⌬, upstream of the transcription start site, would be consistent with transcription running around the plasmid backbone, commonly observed in termination mutants (24 ) . Given the relatively even TRO signals in fkh1⌬ compared with uneven distribution of RNAPII detected by ChIP, we predict that much of the RNAPII at the 3Ј end is not actively engaged in transcription, a likely consequence of the lack of Ser 5 and Ser 2 phosphorylation. We suggest that, at the beginning of genes, the opposing action of Fkh1p versus Fkh2p (together with Dst1p and Spt4p) may be part of RT-PCR assay to detect steady-state RNA at the 3Ј end of IMD2 with primers 1 to 4, at ϩ100, ϩ200, ϩ300, and ϩ400, relative to the translation termination codon, to prime cDNA synthesis on total RNA from strains indicated, followed by PCR amplification with primers indicated. Cells were induced with 100 g/ml 6AU for 60 min before RNA extraction. (C) TRO analysis for IMD2. Pulse-labeled nascent RNA isolated from strains grown in 100 g/ml 6AU was hybridized to 80 base (b) single-stranded DNAs (1 to 12), spanning the 5Ј (1 to 4) and 3Ј (5 to 12) regions of IMD2. A, actin ( positive control); pG, pGEM plasmid (negative control).
the proposed checkpoint mechanism to coordinate transcription and pre-mRNA processing via CTD phosphorylation (17) (fig. S8 ). Furthermore, modulation of the levels (25, 26) or activity (6) of these factors might regulate the release of RNAPII into the elongation phase, allowing transcription in yeast to be matched to the environmental conditions and the availability of nutrients. An outstanding question is how, in the absence of high-affinity binding sites and a cooperative binding partner, the Fkh factors associate with chromatin in coding regions. Like Dst1p, the Fkh factors may directly associate with elongating RNAPII (27) . An alternative possibility is that the Fkh factors are tethered to specific domains of chromatin in coding regions (28) . It remains to be determined how the diverse activities of Fkh factors in metazoans will relate to this demonstrated role in transcriptional elongation. Using three-dimensional infrared high-speed video, we captured the wing and body kinematics of free-flying fruit flies as they performed rapid flight maneuvers. We then "replayed" the wing kinematics on a dynamically scaled robotic model to measure the aerodynamic forces produced by the wings. The results show that a fly generates rapid turns with surprisingly subtle modifications in wing motion, which nonetheless generate sufficient torque for the fly to rotate its body through each turn. The magnitude and time course of the torque and body motion during rapid turns indicate that inertia, not friction, dominates the flight dynamics of insects.
Brisk right-angle turns, termed body saccades, are characteristic of many flies (insects of the order Diptera). Saccades are very fast: A fly can change direction by 90°in less than 50 ms (1-3). To turn, a fly must generate torque to overcome both the inertia of its body and the viscous friction of the air. The relative importance of these forces is largely influenced by body size. Large animals must overcome inertial forces when they accelerate or turn, whereas small animals must overcome the viscous forces acting on their bodies. Current models of flight assume that inertia plays a minor role in the dynamics of 
